Jeevan Scientific Technology Limited (BOM:538837)
81.25
+0.59 (0.73%)
At close: Sep 18, 2026
BOM:538837 Revenue
Jeevan Scientific Technology had revenue of 182.78M INR in the quarter ending June 30, 2026, with 107.72% growth. This brings the company's revenue in the last twelve months to 710.16M, up 66.07% year-over-year. In the fiscal year ending March 31, 2026, Jeevan Scientific Technology had annual revenue of 615.37M with 31.36% growth.
Revenue (ttm)
710.16M
Revenue Growth
+66.07%
P/S Ratio
2.30
Revenue / Employee
2.49M
Employees
285
Market Cap
1.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 615.37M | 146.92M | 31.36% |
| Mar 31, 2025 | 468.46M | 71.95M | 18.15% |
| Mar 31, 2024 | 396.51M | 34.73M | 9.60% |
| Mar 31, 2023 | 361.78M | -323.55M | -47.21% |
| Mar 31, 2022 | 685.33M | 210.50M | 44.33% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Winsome Textile Industries | 9.11B |
| Bal Pharma | 3.34B |
| HB Estate Developers | 1.21B |
| Vaxfab Enterprises | 1.17B |
| Indo Us Bio-Tech | 1.13B |
| Fractal Industries | 897.87M |
| Dhaval Packaging | 650.32M |
| Aartech Solonics | 438.33M |